Here are several platforms that are primarily focused on clinical trial discovery and patient treatment matching:

ClinicalTrials.gov: This is a database of privately and publicly funded clinical studies conducted around the world. It provides information about a trial's purpose, who may participate, locations, and phone numbers for more details[2].

Deep 6 AI: This platform uses artificial intelligence to accelerate patient recruitment for clinical trials. It offers a patient matching and analytics-driven enrollment platform that simplifies the process, reducing risk and improving efficiency[3].

Pentavere Research Group: This is a clinical discovery platform that develops artificial intelligence-based solutions[3].

TriNetX: This is a global health research network that optimizes clinical research and enables discoveries through the generation of real-world evidence[3].

Neuroute: This platform uses AI to help patients find the best treatment options based on their unique health profile[3].

Trialbee: This company focuses on improving enrollment performance in the clinical research sector. It offers a patient matching and analytics-driven enrollment platform[3].

Massive Bio: This digital health company enables pharmaceutical companies to accelerate patient recruitment for clinical trials[3].

Dyania Health: This is an advanced healthcare AI research company that offers a computational-based platform for patient treatment matching[3].

Mendel AI: This company uses AI to help patients find clinical trials that match their health profile[3].

TrialJectory: This platform helps alleviate the workload and burden that cancer clinical trial sites are facing by tracking and optimizing patient matches[8].

Citations:
[1] https://www.withpower.com/clinical-trials/neuroblastoma
[2] https://classic.clinicaltrials.gov/ct2/show/NCT05918432
[3] https://www.cbinsights.com/company/deep6/alternatives-competitors
[4] https://gripable.co
[5] https://www.oasysnow.com
[6] https://www.leal.health
[7] https://www.withpower.com/trial/phase-1-neuroblastoma-5-2020-a0f4c
[8] https://www.linkedin.com/posts/lealhealth_decrease-cancer-clinical-trial-recruitment-activity-6956262761853038592-C78y?trk=public_profile_like_view
[9] https://siliconcanals.com/news/oasys-now-launches-grip/
[10] https://app.oasysnow.com
[11] https://www.withpower.com/trial/phase-1-neuroblastoma-8-2017-bb0c1
[12] https://www.leal.health/terms
[13] https://www.mindtecstore.com/Kinvent-KFORCE-Grip
[14] https://www.withpower.com/trial/phase-2-neuroblastoma-7-2020-197ed
[15] https://myfox8.com/business/press-releases/cision/20240129NY22436/leal-health-partners-with-the-american-cancer-society-to-host-hope-in-the-new-year-webinar
[16] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802493/
[17] https://www.withpower.com/trial/phase-3-neuroblastoma-8-2015-bfe5f
[18] https://aithority.com/natural-language/leal-health-leverages-generative-ai-to-optimize-cancer-treatment-matching-for-patients/
[19] https://content.iospress.com/articles/technology-and-health-care/thc00366
[20] https://www.withpower.com/guides/neuroblastoma-brain-what-you-need-to-know
[21] https://www.cancer.net/blog/2023-02/rebuilding-my-life-after-cancer-and-intensive-treatment-survivor’s-story
[22] https://www.frontiersin.org/articles/10.3389/fpsyg.2022.1026439/full
[23] https://www.withpower.com/trial/phase-3-ganglioneuroblastoma-10-2020-c317f
[24] https://www.linkedin.com/posts/smnichols_hope-in-the-new-year-fireside-chat-presented-activity-7151646684891004930-o2Em
[25] https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-022-02490-2